DEEP-DIVE: Implications of the Drug Supply Shortage Control and Supply Improvement Act for Medical Cannabis
Navigating the post-Covid landscape, German pharmaceutical sector confronts unprecedented supply challenges. A new law, however, aims to reinvigorate the industry. What does this mean for cannabis startups? Get the lowdown on this policy and understand its transformative implications for the medicinal cannabis space